Related Experiment Video
Updated: Jul 17, 2026

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
Published on: January 5, 2017
NPY receptors in human cancer: a review of current knowledge
Meike Körner1, Jean Claude Reubi
1Division of Cell Biology and Experimental Cancer Research, Institute of Pathology, University of Bern, Murtenstrasse 31, PO Box 62, CH-3010 Bern, Switzerland.
Abstract:
Many peptide hormone receptors are over-expressed in human cancer, permitting an in vivo targeting of tumors for diagnostic and therapeutic purposes. NPY receptors are novel and promising candidates in this field. Using in vitro receptor autoradiography, Y1 and Y2 receptors have been found to be expressed in breast carcinomas, adrenal gland and related tumors, renal cell carcinomas, and ovarian cancers in both tumor cells and tumor-associated blood vessels. Pathophysiologically, tumoral NPY receptors may be activated by endogenous NPY released from intratumoral nerve fibers or tumor cells themselves, and mediate NPY effects on tumor cell proliferation and tumoral blood supply. Clinically, tumoral NPY receptors may be targeted with NPY analogs coupled with adequate radionuclides or cytotoxic agents for a scintigraphic tumor imaging and/or tumor therapy.
Insights
Neuropeptide Y (NPY) receptors are over-expressed in several human cancers. Targeting these NPY receptors offers potential for novel cancer diagnostics and therapies.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Peptide hormone receptors are frequently over-expressed in human cancers, presenting opportunities for in vivo tumor targeting.
- Neuropeptide Y (NPY) receptors represent a novel and promising class of targets for cancer diagnostics and therapeutics.
Purpose of the Study:
- To investigate the expression and potential utility of NPY receptors (Y1 and Y2) in various human cancers.
- To explore the pathophysiological role and clinical applications of tumoral NPY receptors.
Main Methods:
- In vitro receptor autoradiography was employed to detect Y1 and Y2 receptor expression.
- Analysis included breast carcinomas, adrenal gland tumors, renal cell carcinomas, and ovarian cancers.
Main Results:
- Y1 and Y2 NPY receptors were found to be expressed in tumor cells and associated blood vessels of the studied cancers.
- Tumoral NPY receptors may be activated by endogenous NPY, influencing tumor cell proliferation and blood supply.
Conclusions:
- Over-expressed NPY receptors in tumors provide a basis for developing new diagnostic and therapeutic strategies.
- Targeting tumoral NPY receptors with NPY analogs could enable scintigraphic tumor imaging and therapeutic interventions.
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Nucleolus
Non-Canonical Wnt Signaling Pathways